Overview

Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults

Status:
Completed
Trial end date:
2020-11-09
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to investigate the relative bioavailability and pharmacokinetics (PK) of sitravatinib free base and malate salt capsule formulations following oral administration in healthy adults.
Phase:
Phase 1
Details
Lead Sponsor:
BeiGene